Global Underwriting Manual Resource Hub
Explore updated underwriting guidelines for asthma and Hodgkin lymphoma.
WELCOME | UPDATES | MEET THE TEAM | RESOURCES
Additional resources
UNDERWRITING
The Respiratory System
See More
Asthma
The latest asthma underwriting guidelines feature updated descriptions, competitive risk tables, and research-based recommendations for accurate risk assessment.
Learn more
Welcome
The latest updates to RGA’s Global Underwriting Manual are now available. This quarter, the resource hub features updated underwriting guidelines for asthma and Hodgkin lymphoma.
Notable updates to asthma underwriting guidelines include a competitive risk classification table and new research-based recommendations for both mortality and morbidity benefits. For Hodgkin lymphoma, you’ll find expanded rating tables, risk classification guidance based on the Ann Arbor Staging System, insights on etiology, and more.
Additionally, we've made minor updates to the underwriting guidelines on:
Family history of cancer
Anal fistulas
Gastrointestinal stromal tumor (GIST)
Autism spectrum disorder (ASD)
RGA is committed to providing you with the tools needed to make informed and effective underwriting decisions. Please reach out if we can provide further resources to support your team’s success.
RESOURCES
New Update
For more information on these updates, log in to the Global Underwriting Manual.
Access now
© 2024 RGA, All rights reserved. RGA has made all reasonable efforts to ensure that the information provided in this publication is accurate at the time of inclusion and accepts no liability for any inaccuracies or omissions. Links to external websites are provided for informational purposes only. RGA bears no responsibility for the accuracy, legality, or content of external websites.
Connect with us
Meet our experts
Dr. Sheetal Salgaonkar
Vice President, Global Medical Director
Hodgkin Lymphoma
The updated guidelines for Hodgkin lymphoma include expanded rating tables, risk classification guidance based on the Ann Arbor Staging System as well as insights on etiology, signs and symptoms, and treatment toxicity.
Learn more
New Update
Dr. Reema Nathwani Jani
Associate Director - Global Underwriting, Manual Research
CONTACT US: For further information or to connect with your regional contact, email GUMHelp@rgare.com
John Cardus
Vice President, Head of Underwriting Manual Development
Read bio
Read bio
As Associate Director, Dr. Reema Nathwani Jani focuses on underwriting research and the development of the Global Underwriting Manual. With a medical degree and a master's in Psychotherapy, she brings over a decade of direct insurance underwriting experience, including high-value cases, product development, claims consultation and tele-underwriting initiatives. She is actively engaged with the broader industry, frequently sharing her insights and expertise at various industry events.
close
Dr. Reema Nathwani Jani
Associate Director - Global Underwriting, Manual Research
Dr. Sheetal Salgaonkar, RGA's Vice President and Global Medical Director, specializes in underwriting and claims consultation, product development and trains underwriters and claim assessors globally. Contributing to underwriting guidelines and curriculums for insurance education, she brings experience as a former intensivist and Chief Medical Officer at ICICI Prudential. Based in India, Dr. Sheetal is a certified MD, a Diplomat of Board of Insurance Medicine, and the 2022 Charles A. Will Award recipient for her outstanding FALU exam performance.
close
Dr. Sheetal Salgaonkar
Vice President, Global Medical Director
UNDERWRITING
The ABCs of PFTs
See More
UNDERWRITING
Take a Breather: Common Lung Diseases
See More
Trusted partner.
Proven results.
BACK TO TOP
Dr. Daniel Zimmerman reviews the recent and unprecedented acceleration in the understanding of cancer pathophysiology, which has led to the subsequent development of novel cancer immunotherapies. In part, this new direction in cancer treatment has been advanced by a greater understanding of individual patient genomics and has contributed to the realization of the so-called “precision medicine” era.
Cancer Immunotherapy: A rapidly expanding frontier
Read more
Share:
WELCOME
UPDATES
MEET THE TEAM
RESOURCES
Sushama Singh
Chief Manager - Research and Manual Development
Read bio
As Chief Manager, Sushama Singh spearheads underwriting research and the content development of RGA's Global Underwriting Manual. She holds degrees in Medicine and Law from Mumbai University and an ALMI designation by LOMA. With 18 years of underwriting experience, Sushama has expertise in handling high-net-worth cases, product development, reinsurance treaty discussions, underwriting manual governance and interpreting treadmill tests (TMT) and ECGs.
close
Sushama Singh
Chief Manager - Research and Manual Development
Sushama Singh
Chief Manager - Research and Manual Development
Read bio
close
Sushama Singh
Chief Manager - Research and Manual Development
UNDERWRITING
The Lymphatic System
See More
UNDERWRITING
The Multiple Personas of Lymphomas:
See More
claims
Lymphoma and Leukemia
See More
Underwriting and Claims Training
ADDITIONAL RESOURCES
Global Underwriting Hub Q2
Dr. Daniel Zimmerman reviews the recent and unprecedented acceleration in the understanding of cancer pathophysiology, which has led to the subsequent development of novel cancer immunotherapies. In part, this new direction in cancer treatment has been advanced by a greater understanding of individual patient genomics and has contributed to the realization of the so-called “precision medicine” era.
Cancer Immunotherapy: A rapidly expanding frontier
READ MORE
UNDERWRITING
The Respiratory System
See More
UNDERWRITING
The ABCs of PFTs
See More
UNDERWRITING
Take a Breather: Common Lung Diseases
See More
RESOURCES
Coronary Artery Disease (CAD) remains an increasingly complex disease to underwrite. RGA’s Global Underwriting Manual has recently been updated to reflect the latest in clinical advancements and risk assessment. The updates include guidelines dedicated to both clinical and asymptomatic CAD, a new Coronary Artery Calcium Calculator, and an assessment to address myocardial bridging risks.
Coronary Artery Disease Resource Hub
Explore the hub
MORE FROM RGA
Explore now
Advancing Mental Health in Insurance
RGA recognizes the opportunity to drive improvements in mental health support across the insurance industry. We continue to enhance advocacy, education, and accessibility for inclusive coverage of these complex conditions. This involves shifting our approach to risk assessment across underwriting, claims, and medical. Equip your team with resources to champion mental health inclusion within the insurance industry.
